Literature DB >> 27853810

Inflammation, but not recruitment, of adipose tissue macrophages requires signalling through Mac-1 (CD11b/CD18) in diet-induced obesity (DIO).

Dennis Wolf, Nora Bukosza, David Engel, Marjorie Poggi, Felix Jehle, Nathaly Anto Michel, Yung-Chih Chen, Christian Colberg, Natalie Hoppe, Bianca Dufner, Louis Boon, Hermann Blankenbach, Ingo Hilgendorf, Constantin von Zur Muhlen, Jochen Reinöhl, Björn Sommer, Timoteo Marchini, Mark A Febbraio, Christian Weber, Christoph Bode, Karlheinz Peter1, Esther Lutgens, Andreas Zirlik.   

Abstract

Cell accumulation is a prerequisite for adipose tissue inflammation. The leukocyte integrin Mac-1 (CD11b/CD18, αMβ2) is a classic adhesion receptor critically regulating inflammatory cell recruitment. Here, we tested the hypothesis that a genetic deficiency and a therapeutic modulation of Mac-1 regulate adipose tissue inflammation in a mouse model of diet-induced obesity (DIO). C57Bl6/J mice genetically deficient (Mac-1-/-) or competent for Mac-1 (WT) consumed a high fat diet for 20 weeks. Surprisingly, Mac-1-/- mice presented with increased diet-induced weight gain, decreased insulin sensitivity in skeletal muscle and in the liver in insulin-clamps, insulin secretion deficiency and elevated glucose levels in fasting animals, and dyslipidaemia. Unexpectedly, accumulation of adipose tissue macrophages (ATMs) was unaffected, while gene expression indicated less inflamed adipose tissue and macrophages in Mac-1-/- mice. In contrast, inflammatory gene expression at distant locations, such as in skeletal muscle, was not changed. Treatment of ATMs with an agonistic anti-Mac-1 antibody, M1/70, induced pro-inflammatory genes in cell culture. In vivo, treatment with M1/70 induced a hyper-inflammatory phenotype with increased expression of IL-6 and MCP-1, whereas accumulation of ATMs did not change. Finally, inhibition of Mac-1's adhesive interaction to CD40L by the peptide inhibitor cM7 did not affect myeloid cell accumulation in adipose tissue. We present the surprising finding that adhesive properties of the leukocyte integrin Mac-1 are not required for macrophage accumulation in adipose tissue. Instead, Mac-1 modulates inflammatory gene expression in macrophages. These findings question the net effect of integrin blockade in cardio-metabolic disease.

Entities:  

Keywords:  Obesity; adhesion molecules; inflammation; macrophage; metabolic disorders

Mesh:

Substances:

Year:  2016        PMID: 27853810     DOI: 10.1160/TH16-07-0553

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  11 in total

Review 1.  Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation.

Authors:  Joseph R Scalea; Young Suk Lee; Eduardo Davila; Jonathan S Bromberg
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

2.  Thrombin promotes diet-induced obesity through fibrin-driven inflammation.

Authors:  Anna K Kopec; Sara R Abrahams; Sherry Thornton; Joseph S Palumbo; Eric S Mullins; Senad Divanovic; Hartmut Weiler; A Phillip Owens; Nigel Mackman; Ashley Goss; Joanne van Ryn; James P Luyendyk; Matthew J Flick
Journal:  J Clin Invest       Date:  2017-07-24       Impact factor: 14.808

3.  Inhibition of integrin αDβ2-mediated macrophage adhesion to end product of docosahexaenoic acid (DHA) oxidation prevents macrophage accumulation during inflammation.

Authors:  Kui Cui; Nataly P Podolnikova; William Bailey; Eric Szmuc; Eugene A Podrez; Tatiana V Byzova; Valentin P Yakubenko
Journal:  J Biol Chem       Date:  2019-08-08       Impact factor: 5.157

4.  Modification of Extracellular Matrix by the Product of DHA Oxidation Switches Macrophage Adhesion Patterns and Promotes Retention of Macrophages During Chronic Inflammation.

Authors:  Jared L Casteel; Kasey R Keever; Christopher L Ardell; David L Williams; Detao Gao; Eugene A Podrez; Tatiana V Byzova; Valentin P Yakubenko
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

5.  Frontline Science: The expression of integrin αD β2 (CD11d/CD18) on neutrophils orchestrates the defense mechanism against endotoxemia and sepsis.

Authors:  William P Bailey; Kui Cui; Christopher L Ardell; Kasey R Keever; Sanjay Singh; Diego J Rodriguez-Gil; Tammy R Ozment; David L Williams; Valentin P Yakubenko
Journal:  J Leukoc Biol       Date:  2021-01-13       Impact factor: 4.962

6.  CD18 deficiency improves liver injury in the MCD model of steatohepatitis.

Authors:  Andrew A Pierce; Caroline C Duwaerts; Kevin Siao; Aras N Mattis; Amanda Goodsell; Jody L Baron; Jacquelyn J Maher
Journal:  PLoS One       Date:  2017-09-05       Impact factor: 3.240

7.  Distinct Migratory Properties of M1, M2, and Resident Macrophages Are Regulated by αDβ2 and αMβ2 Integrin-Mediated Adhesion.

Authors:  Kui Cui; Christopher L Ardell; Nataly P Podolnikova; Valentin P Yakubenko
Journal:  Front Immunol       Date:  2018-11-15       Impact factor: 7.561

Review 8.  CD40L and Its Receptors in Atherothrombosis-An Update.

Authors:  Nathaly Anto Michel; Andreas Zirlik; Dennis Wolf
Journal:  Front Cardiovasc Med       Date:  2017-06-20

9.  A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.

Authors:  Dennis Wolf; Nathaly Anto-Michel; Hermann Blankenbach; Ansgar Wiedemann; Konrad Buscher; Jan David Hohmann; Bock Lim; Marina Bäuml; Alex Marki; Maximilian Mauler; Daniel Duerschmied; Zhichao Fan; Holger Winkels; Daniel Sidler; Philipp Diehl; Dirk M Zajonc; Ingo Hilgendorf; Peter Stachon; Timoteo Marchini; Florian Willecke; Maximilian Schell; Björn Sommer; Constantin von Zur Muhlen; Jochen Reinöhl; Teresa Gerhardt; Edward F Plow; Valentin Yakubenko; Peter Libby; Christoph Bode; Klaus Ley; Karlheinz Peter; Andreas Zirlik
Journal:  Nat Commun       Date:  2018-02-06       Impact factor: 14.919

10.  Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus.

Authors:  Catalina Burbano; Juan Villar-Vesga; Janine Orejuela; Carlos Muñoz; Adriana Vanegas; Gloria Vásquez; Mauricio Rojas; Diana Castaño
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.